Results 111 to 120 of about 762,366 (142)

IdentifiHR predicts homologous recombination deficiency in high-grade serous ovarian carcinoma using gene expression. [PDF]

Commun Med (Lond)
Weir AL, Lee SC, Li M, Pandey A, Tan CW, Garsed DW, Ramus SJ, Davidson NM.   +7 more
europepmc   +1 more source

Interaction between ENPP1 and homologous recombination deficiency defines distinct pan-cancer signatures: A retrospective observational study. [PDF]

Medicine (Baltimore)
Kim YM, Lee SH, Na W, Lee IJ, Kwon M, Jo O, Song YS.   +6 more
europepmc   +1 more source

Comprehensive genomic profiling for homologous recombination deficiency guides PARP inhibitor therapy recommendations in ovarian cancer. [PDF]

Pathol Oncol Res
Inci A, Witzel I, Moch H, Rahmani-Khajouei S, Zoche M, Samartzis EP.   +5 more
europepmc   +1 more source

Homologous Recombination Deficiency in Ovarian and Breast Cancers: Biomarkers, Diagnosis, and Treatment. [PDF]

Curr Issues Mol Biol
Shah B, Hussain M, Seth A.
europepmc   +1 more source

Identification of prognostic markers related to homologous recombination deficiency in cholangiocarcinoma using CoxBoost and LASSO machine learning techniques. [PDF]

Front Immunol
Liu Y, Zhou C, Shen T, Yu X, Li Q, Jiang T, Li W, Zhu Y.   +7 more
europepmc   +1 more source

Prevalence of homologous recombination deficiency in ovarian, primary peritoneal, and/or fallopian tube cancer: results from HALO-Taiwan subset. [PDF]

J Gynecol Oncol
Liou WS, Chao A, Sheu BC, Yeh LS, Wu CH.
europepmc   +1 more source

CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer. [PDF]

Commun Biol
Romanovsky E, Menzel M, Kluck K, Beck S, Ball M, Schirmacher P, Kazdal D, Stenzinger A, Budczies J.   +8 more
europepmc   +1 more source

Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study. [PDF]

Breast Cancer Res Treat
Masuda N, Yasojima H, Bando H, Yamanaka T, Shigematsu H, Takahashi M, Nagai SE, Ito M, Aruga T, Tokiwa M, Imoto S, Nakamura R, Ishiguro H, Kawabata H, Saji S, Haga H, Morita S, Toi M.   +17 more
europepmc   +1 more source

Homologous recombination deficiency in breast cancer: genomic characteristics, clinical implications, and predictive value in neoadjuvant therapy. [PDF]

Front Oncol
Huang J, Luan F, Yan L, Liang X, Ma X, An Y, Hu S, Gao G, Wang Y, Yang J, Dong D.   +10 more
europepmc   +1 more source

Robust Assessment of Homologous Recombination Deficiency Genomic Instability by OncoScan Microarrays. [PDF]

J Mol Diagn
Lara Gutierrez A, Halbwedl I, Sauer S, Regitnig P, Petru E, Seeböck R, Schubert S, Peternell C, Bodó K, Prein K, Kashofer K.   +10 more
europepmc   +1 more source